Form EFFECT iTeos Therapeutics, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 4, 2025 |
| Accession Number: | 0001140361-25-033424 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- International Paper CEO to Speak at Jefferies 2026 Industrials Conference
- Exodus Movement, Inc. to Announce Second Quarter 2026 Results on August 10, 2026
- Hawke Electric Vehicles Expands Hire and Sales Operations to Full Nationwide Coverage Across the UK
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
